Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Wegovy
Payers
Optum Rx: Why payers should be watching these 3 pipeline drugs
Three drugs treating chronic conditions are set for FDA review by the end of the year, and a new Optum Rx report digs into why payers should watch.
Paige Minemyer
Nov 26, 2025 1:30pm
Fierce Pharma
Lilly, Novo reach GLP-1 pricing deals with White House
Nov 6, 2025 12:26pm
Talkspace boosts AI innovation, inks Novo Nordisk partnership
Oct 31, 2025 1:00pm
CVS hit with lawsuit over dropping Zepbound from formulary
Sep 5, 2025 4:58pm
CMMI eyes weight loss drug coverage as IVF pledge slips: reports
Aug 4, 2025 2:50pm
Hims & Hers to offer generic semaglutide drugs in Canada
Jul 11, 2025 3:30pm